Regulatory Affairs

Through decades of experience, we bring real-world knowledge to advance your goals faster.

Our Regulatory Affairs expertise and services include:

Preclinical & clinical development regulatory strategy:

Navigating regulatory pathways for new drugs, devices, and diagnostics from pre-IND (Investigational New Drug) to NDA (New Drug Application) or PMA (Premarket Approval) submission.

Regulatory writing & submissions:

Developing high-quality regulatory documents like INDs, NDAs, and BLAs (Biologics License Applications), ensuring compliance with all relevant regulations.

Regulatory due diligence:

Assessing the regulatory landscape and potential risks associated with potential acquisitions or partnerships.

Post-approval support:

Managing post-marketing regulatory requirements, including variations submissions and responding to regulatory inquiries.